Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Advertisement
The Scientist
Most Recent
Scientist? Filmmaker? Alexis Gambis welcomes both labels.
A new play explores the mind of the father of modern physics through his interactions—factual and imagined—with a curmudgeonly colleague.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
A new journal that publishes peer review comments alongside its manuscripts goes live.
Why so few scientists make the leap to policy-making positions, and why more should give it a try
Some of the 200 or so human embryonic stem cell lines approved for federal funding may have been derived from sperm or eggs of unconsenting donors.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Globally, 15-year-old girls outscored boys in 43 of the 65 countries tested.
In Chapter 1, “A Theory,” author Aaron James constructs a working definition for the type of person that earns the ignominious moniker.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
